REFERENCES
1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Eur Heart J . 2016;37(38):2893-2962. doi:10.1093/eurheartj/ehw210
2. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation . 2003;107(23):2920-2925. doi:10.1161/01.CIR.0000072767.89944.6E
3. Khan MN, Jaïs P, Cummings J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med . 2008;359(17):1778-1785. doi:10.1056/NEJMoa0708234
4. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol . 2014;7(1):31-38. doi:10.1161/CIRCEP.113.000806
5. Di Biase L, Mohanty P, Mohanty S, et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Circulation . 2016;133(17):1637-1644. doi:10.1161/CIRCULATIONAHA.115.019406
6. Marrouche NF, Brachmann J, Andresen D, et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med . 2018;378(5):417-427. doi:10.1056/NEJMoa1707855
7. Cha YM, Wokhlu A, Asirvatham SJ, et al. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function.Circ Arrhythm Electrophysiol . 2011;4(5):724-732. doi:10.1161/CIRCEP.110.960690
8. Machino-Ohtsuka T, Seo Y, Ishizu T, et al. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. J Am Coll Cardiol . 2013;62(20):1857-1865. doi:10.1016/j.jacc.2013.07.020
9. Chen MS, Marrouche NF, Khaykin Y, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol . 2004;43(6):1004-1009. doi:10.1016/j.jacc.2003.09.056
10. Sohns C, Saguner AM, Lemes C, et al. First clinical experience using a novel high-resolution electroanatomical mapping system for left atrial ablation procedures. Clin Res Cardiol . 2016;105(12):992-1002. doi:10.1007/s00392-016-1008-7
11. Schaeffer B, Hoffmann BA, Meyer C, et al. Characterization, Mapping, and Ablation of Complex Atrial Tachycardia: Initial Experience With a Novel Method of Ultra High-Density 3D Mapping. J Cardiovasc Electrophysiol . 2016;27(10):1139-1150. doi:10.1111/jce.13035
12. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J . 2021;42(5):373-498. doi:10.1093/eurheartj/ehaa612
13. Lutomsky BA, Rostock T, Koops A, et al. Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace . 2008;10(5):593-599. doi:10.1093/europace/eun076
14. Ullah W, Ling LH, Prabhu S, et al. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.Europace . 2016;18(5):679-686. doi:10.1093/europace/euv440
15. Black-Maier E, Ren X, Steinberg BA, et al. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. Heart Rhythm . 2018;15(5):651-657. doi:10.1016/j.hrthm.2017.12.001
16. Yang PS, Park YA, Kim TH, et al. Which patients recur as atrial tachycardia rather than atrial fibrillation after catheter ablation of atrial fibrillation? PLoS ONE . 2017;12(11):e0188326. doi:10.1371/journal.pone.0188326
17. Diamant MJ, Andrade JG, Virani SA, Jhund PS, Petrie MC, Hawkins NM. Heart failure and atrial flutter: a systematic review of current knowledge and practices. ESC Heart Fail . 2021;8(6):4484-4496. doi:10.1002/ehf2.13526
18. Takigawa M, Derval N, Frontera A, et al. Revisiting anatomic macroreentrant tachycardia after atrial fibrillation ablation using ultrahigh-resolution mapping: Implications for ablation. Heart Rhythm . 2018;15(3):326-333. doi:10.1016/j.hrthm.2017.10.029
19. Kitamura T, Martin R, Denis A, et al. Characteristics of Single-Loop Macroreentrant Biatrial Tachycardia Diagnosed by Ultrahigh-Resolution Mapping System. Circ Arrhythm Electrophysiol . 2018;11(2):e005558. doi:10.1161/CIRCEP.117.005558
20. Providencia R, Elliott P, Patel K, et al. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis. Heart . 2016;102(19):1533-1543. doi:10.1136/heartjnl-2016-309406
21. Hindricks G, Weiner S, McElderry T, et al. Acute safety, effectiveness, and real-world clinical usage of ultra-high density mapping for ablation of cardiac arrhythmias: results of the TRUE HD study. Europace . 2019;21(4):655-661. doi:10.1093/europace/euy191